(Q41702320)

English

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma

scientific article published on August 1999

Statements

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma (English)
1 August 1999
2521-2529

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit